GFAP and Alzheimer disease: Western blot analysis of the hippocampus also revealed no difference in GFAP protein levels between 3xTg-AD mice treated, or not treated with AAV-NF-α1/CPE, and non-Tg mice, indicating no changes in glial cell quantity (Fig. 3E).